Home
GHRH (1–44) Analog Amide
-20%
Regular price £29.99 GBP Sale price £23.99 GBP
In stock
Order in the next [hours] hours [mins] minutes
to get delivery on
UK HPLC Tested - UKAS & ISO 9001 - >99% Purity
-20°C Cold-Chain Storage
Same-Day Dispatch (Before 4pm)
Free UK Shipping Over £100
Certificate of Analysis (COA): See Images
Tesamorelin is a synthetic peptide analogue of growth hormone–releasing hormone (GHRH). It has been of strong interest in laboratory research for its ability to stimulate growth hormone release and impact metabolic pathways. Preclinical and clinical research studies have highlighted Tesamorelin’s potential roles in body composition, lipid metabolism, and age-related endocrine investigations. While not approved for research outside specific regulated uses, Tesamorelin continues to attract attention as an exciting peptide in metabolic and endocrine-focused research.
Area of Interest
Research into Tesamorelin has focused on:
Growth Hormone Stimulation: Studied for its capacity to bind GHRH receptors, leading to increased growth hormone secretion in experimental models. Metabolic Research: Explored in relation to fat metabolism, insulin sensitivity, and body composition changes in laboratory investigations. Lipid Studies: Preclinical and early clinical research has assessed its influence on triglyceride and cholesterol regulation. Aging and Endocrinology: Considered in studies looking at hormonal regulation and the physiological changes of aging.
Together, these studies reflect Tesamorelin’s value as a research tool for exploring growth hormone pathways and metabolic health.
Technical Information
Chemical Name: Tesamorelin acetate Synonyms: Egrifta, TH9507 Molecular Formula: C221H366N72O67S Molecular Weight: ~5135 g/mol Sequence (Amino Acid): His-Trp-Ala-Trp-D-Phe-Lys-Val-Tyr-D-Trp-Leu-Lys-Val-Lys CAS Number: 218949-48-5 Peptide Classification: Synthetic peptide analogue of human growth hormone–releasing hormone (GHRH)
Storage Guidelines
Lyophilized peptide is stable at room temperature for short periods. For long-term storage, keep at −20 °C or below. Once reconstituted, store at 2–8 °C. Effective use period may vary depending on the solution used.
Solubility
Tesamorelin is soluble in sterile water or other aqueous buffers depending on formulation and purity.
References
Fauci, A. S., et al. (2009). “Tesamorelin, a growth hormone–releasing factor analogue, decreases visceral fat in HIV-infected patients with lipodystrophy.” New England Journal of Medicine, 361, 912–922. https://doi.org/10.1056/NEJMoa0903269 Falutz, J., et al. (2005). “Metabolic effects of tesamorelin, a growth hormone–releasing factor analogue, in HIV patients.” Annals of Internal Medicine, 143(5), 347–356. https://doi.org/10.7326/0003-4819-143-5-200509060-00007 Allas, S., & Caron, P. (2011). “Tesamorelin: a growth hormone–releasing factor analogue for the treatment of HIV-associated lipodystrophy.” Expert Opinion on Pharmacotherapy, 12(15), 2405–2413. https://doi.org/10.1517/14656566.2011.608699
GHRH (1–44) Analog Amide
Feature
Tide Labs
Typical suppliers
Purity Testing
Independent HPLC at a UKAS & ISO 9001 accredited UK lab
Self-reported or overseas lab with no accreditation
Certificate of Analysis
Full COA's - UK Tested, 99%+ Purity
Generic or unavailable — often only on request
Storage Conditions
-20°C cold-chain from receipt to dispatch
Room temperature or uncontrolled warehouse
Shipping
Temperature-shielded Mylar + same-day dispatch before 4pm
Standard packaging, 2-5 day processing
Vial Quality
Type 1 pharmaceutical-grade borosilicate glass
Type 2/3 soda-lime glass — risk of heavy metal leaching
Supply Chain
Fully documented UK-based chain of custody
Opaque — often rebadged from unknown overseas sources
Recently viewed products